LexBlog IP

FEBRUARY 7, 2023

Sockeye has sued approximately 80 defendants since it began its patent infringement campaigns in 2015. For example, Sockeye sued a group of electronics companies in 2015 and sued the same defendants again in 2022 with at least some of the same patents. So what happened?

Licensing 40

Licensing Settlement Patent Troll Confidentiality 40

SpicyIP

MARCH 11, 2024

Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Anything we are missing out on? Please let us know in the comments below.

Trademark 59

Trademark Registration Copyright Patent 59

The IPKat

SEPTEMBER 12, 2021

A primary motivation for Abbott's expedition application was to obtain a UK court decision on the validity of four European patents in order to influence a German court considering infringement of the German EP equivalents and to prevent the problems of the "injunction gap".

Litigation 98

Litigation Patent Marketing Marketing 98

Patently-O

FEBRUARY 22, 2023

Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. It generally amounts to more than 50% of the total settlement recovery, acknowledging, at least by basic math, that they are the primary beneficiary of the litigation.).

Litigation 124

Litigation Reporting Settlement Government 124

LexBlog IP

APRIL 3, 2023

This decision indicates that an SEP owner sometimes might need to provide information to a prospective licensee (under a confidentiality agreement), although that may not be necessary for an experienced licensee who can consult existing patent licenses they have entered with others. non-discriminatory] part of FRAND).

Licensing 52

Licensing Technology Intellectual Property Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Figure 1 below provides an overview of biosimilar approvals by FDA and product launches in the United States from 2015 to 2021. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . 2015; resubmitted Feb. No earlier than 2023 per settlement.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

JUNE 7, 2023

19] Parties to a SEP dispute would be required to go through the conciliation procedure before they can initiate patent infringement proceedings or a FRAND assessment before a Member State court or the UPC. [20] Confidential nature of the EUIPO’s findings. Only the latter will be publicly available. [29]

Licensing 52

Licensing Patent Confidentiality Registration 52